Valuation: Sudarshan Pharma Industries Limited

Market Cap 9.4B 98.74M 88.44M 81.59M 73.84M 138M 140M 973M 388M 4.92B 371M 363M 15.59B P/E 2025
46.3x
P/E 2026 25x
Enterprise Value 12.24B 129M 115M 106M 96.13M 180M 183M 1.27B 506M 6.41B 482M 472M 20.29B EV / Sales 2025
1.79x
EV / Sales 2026 1.23x
Free-Float
22.19%
Yield 2025 *
-
Yield 2026 -
10-06 Sudarshan Pharma Industries Limited, along with its promoters Hemal Mehta and Sachin Mehta, cancelled the agreement to acquire a 12.5% stake in Medtherapy Biotechnology Inc. CI
09-27 Amit Jatin Mehta acquired 51% stake in Ishwari Healthcare Pvt Ltd from Sudarshan Pharma Industries Limited for INR 14 million. CI
09-04 Sudarshan Pharma Industries Limited, Hemal Mehta and Sachin Mehta, agreed to acquire 12.5% stake in Medtherapy Biotechnology Inc. CI
08-12 Sudarshan Pharma Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
06-10 Sudarshan Pharma Industries Limited Incorporates Wholly-Owned Subsidiary In United States Of America CI
05-12 Sudarshan Pharma Industries Ltd to consider issuance of foreign currency convertible bonds RE
05-04 Sudarshan Pharma Industries CFO Resigns; Shares up 3% MT
04-30 Sudarshan Pharma Industries Limited Announces Resignation of Sachin Mehta as Chief Financial Officer, Effective May 1, 2026 CI
04-30 Sudarshan Pharma Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
03-28 4,813,182 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 29-MAR-2026. CI
02-26 Sudarshan Pharma Industries says GST inspection conducted by Mumbai Tax Department RE
01-28 Sudarshan Pharma Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
12-30 Sudarshan Pharma Industries Limited completed the acquisition of Ratna Lifesciences Pvt Ltd. CI
1 day-1.75%
1 week+9.32%
Current month-0.94%
1 month-3.40%
3 months-6.97%
6 months+23.17%
Current year+34.12%
1 week 29.01
Extreme 29.01
39.37
1 month 29.01
Extreme 29.01
39.37
Current year 18.5
Extreme 18.5
42.79
1 year 18.5
Extreme 18.5
42.79
3 years 5.82
Extreme 5.82
53.5
5 years 5.18
Extreme 5.185
53.5
10 years 5.18
Extreme 5.185
53.5
Manager TitleAgeSince
Chief Executive Officer 41 2018-11-07
Chief Executive Officer 48 2018-11-07
Chief Operating Officer - 2025-10-31
Director TitleAgeSince
Chairman 48 2018-11-07
Director/Board Member 41 2025-08-13
Director/Board Member 32 2023-07-20
Change 5-day change 1-year change 3-year change Capi.($)
-1.75%+9.32%+57.30%+355.16% 100M
+6.63%+8.10%+67.50%+145.20% 1,148B
+1.53%+6.76%+47.22%+89.01% 652B
+1.68%+2.10%+27.80%+109.31% 505B
+0.73%+2.47%+53.85%+68.96% 384B
+3.83%-2.37%+68.14%+42.32% 348B
+2.38%+4.27%+33.81%+57.95% 294B
+2.26%+3.47%+5.21%+28.92% 264B
+1.97%+5.11%+57.74%+76.14% 244B
+4.03%+7.84%+40.49%+116.14% 197B
Average +2.88%+2.38%+45.91%+108.91% 403.73B
Weighted average by Cap. +3.75%+1.50%+49.58%+95.98%

Financials

2025 2026
Net sales 5.05B 53.04M 47.5M 43.83M 39.66M 74.16M 75.36M 523M 209M 2.64B 199M 195M 8.37B 7.03B 73.83M 66.13M 61.01M 55.21M 103M 105M 728M 290M 3.68B 277M 271M 11.65B
Net income 160M 1.68M 1.5M 1.38M 1.25M 2.34M 2.38M 16.52M 6.59M 83.5M 6.29M 6.15M 264M 233M 2.45M 2.19M 2.02M 1.83M 3.42M 3.48M 24.13M 9.62M 122M 9.18M 8.99M 386M
Net Debt 1.69B 17.71M 15.87M 14.64M 13.25M 24.77M 25.17M 175M 69.67M 883M 66.48M 65.06M 2.8B 2.84B 29.81M 26.7M 24.64M 22.29M 41.69M 42.36M 294M 117M 1.49B 112M 110M 4.71B
Projected Income Statement - Annual - Sudarshan Pharma Industries Limited
Logo Sudarshan Pharma Industries Limited
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in manufacturing, having a plant for API and doing jobwork manufacturing in Pharmaceutical Items and traders in Chemicals and Solvents in India. The Company is involved in specialty chemicals and intermediates for pharma, agricultural chemicals, coating, paints, adhesive, and various other industries. It is also focused on active pharmaceutical ingredient manufacturing. It is also into specialty chemicals imports and exports, as well as supplying the same to the actual users. The Company provides customized specialty chemicals to its clients in India and abroad regularly. The Company is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, non-governmental organizations (NGO) and hospitals. The Company operates in the states of Maharashtra, Gujarat and Uttarakhand.
Employees
64
Date Price Change Volume
26-10-29 ₹36.95 -1.75% 26,732
26-10-28 ₹37.61 +7.83% 81,880
26-10-27 ₹34.88 +9.03% 51,590
26-10-26 ₹31.99 +2.37% 240,000
26-10-23 ₹31.25 -4.05% 40,000
  1. Stock Market
  2. Stocks
  3. SUDARSHAN Stock